Christopher Shubert

5PUBLICATIONS
67CO-AUTHORS
Haematological tumoursTumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 18, 2026
Hepatocellular Carcinoma Arising From Well-Differentiated Hepatocellular Neoplasm of Uncertain Malignant Potential in a Patient With Abernethy Malformation.

|Jul 15, 2026
Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database.

|May 05, 2026
Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic Cancer.

|Aug 14, 2024
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC.

Mari Nakazawa, Mike Fang, Tyrus Vong

|Feb 17, 2023
Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancer.

Ming Cui, Sami Shoucair, Quan Liao

Pageof 1

Frequent Collaborators

3 joint publications

Kelly J Lafaro

2 joint publications

Jin He

2 joint publications

Jacquelyn W Zimmerman

2 joint publications

Lei Zheng